Skip to main content

Peer Review reports

From: Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

Original Submission
13 Dec 2010 Submitted Original manuscript
17 Oct 2011 Author responded Author comments - TF Cheng
27 Jan 2011 Reviewed Reviewer Report - Michael Gnant
Resubmission - Version 2
17 Oct 2011 Submitted Manuscript version 2
29 Nov 2011 Author responded Author comments - TF Cheng
29 Oct 2011 Reviewed Reviewer Report - Michael Gnant
Resubmission - Version 3
29 Nov 2011 Submitted Manuscript version 3
Publishing
21 Jan 2012 Editorially accepted
21 Jan 2012 Article published 10.1186/1471-2407-12-33

You can find further information about peer review here.

Back to article page
\